Literature DB >> 9570490

Quality of life in schizophrenia and dysthymia.

S Gupta1, P Kulhara, S K Verma.   

Abstract

Quality of life (QOL) was assessed in three groups of patients, consisting of 30 schizophrenic patients with duration of illness <2 years, 30 schizophrenic patients with duration of illness > or = 2 years and 30 dysthymic patients. The diagnoses were made according to ICD-10. Two scales of quality of life were used, one of which was specific for schizophrenia, while the other was generic for all patients. On inter-group comparison the two schizophrenia groups did not show significant differences in quality of life, but on comparing schizophrenic and dysthymic patients, significant differences emerged. Dysthymic patients were significantly less satisfied than schizophrenic patients with duration of illness <2 years in the domain of physical health. In the domains of satisfaction with medication and leisure-time activities, both schizophrenic groups were significantly more satisfied than the dysthymic group. Comparison of the quality of life ratings of our patients with those of a well-known study from Sweden revealed some significant differences which relate to the domains of work, contacts, inner experience and leisure-time activities. Cultural factors are invoked to account for these differences. The need for refinement of assessment of quality of life in multi-racial and multi-ethnic contexts is stressed.

Entities:  

Mesh:

Year:  1998        PMID: 9570490     DOI: 10.1111/j.1600-0447.1998.tb10002.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Subjective quality of life of community living Sudanese psychiatric patients: comparison with family caregivers' impressions and control group.

Authors:  A W Awadalla; J U Ohaeri; A A Salih; A M Tawfiq
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Which is A More Debilitating Disorder Schizophrenia or Dysthymia? - A Comparative Study.

Authors:  Shaunak A Ajinkya; Pradeep R Jadhav; Shruti Rajamani
Journal:  J Clin Diagn Res       Date:  2015-05-01

3.  Adult quality of life and associated factors in adolescent onset schizophrenia and affective psychotic disorders.

Authors:  Håkan Jarbin; Lars Hansson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-09       Impact factor: 4.328

4.  Predictors of frequent recourse to health professionals by people with severe mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita
Journal:  Can J Psychiatry       Date:  2015-02       Impact factor: 4.356

5.  Subjective quality of life in severely mentally ill patients: a comparison of two instruments.

Authors:  M Ritsner; R Kurs; H Kostizky; A Ponizovsky; I Modai
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

6.  Convergent validity of quality of life interview (qoli) in an Indian setting: preliminary findings.

Authors:  Aprajita Lobana; Surendra K Mattoo; Debasish Basu; Nitin Gupta
Journal:  Indian J Psychiatry       Date:  2002-04       Impact factor: 1.759

7.  Relationship between religiosity and psychopathology in patients with depression.

Authors:  Swapnil Gupta; Ajit Avasthi; Suresh Kumar
Journal:  Indian J Psychiatry       Date:  2011-10       Impact factor: 1.759

8.  Schizophrenia: Impact on quality of life.

Authors:  Ram Kumar Solanki; Paramjeet Singh; Aarti Midha; Karan Chugh
Journal:  Indian J Psychiatry       Date:  2008-07       Impact factor: 1.759

9.  Predictors of quality of life in a longitudinal study of users with severe mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jacques Tremblay; Norbert Schmitz; Jean Caron
Journal:  Health Qual Life Outcomes       Date:  2013-06-08       Impact factor: 3.186

10.  Body mass index and quality of life among outpatients with schizophrenia in Japan.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Yasushi Sato; Manabu Saito; Hanako Furukori; Taku Nakagami; Shuhei Kudo; Sunao Kaneko
Journal:  BMC Psychiatry       Date:  2013-04-09       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.